Literature DB >> 11809710

Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft.

Kazuo Shirakawa1, Hisataka Kobayashi, Yuji Heike, Satomi Kawamoto, Martin W Brechbiel, Fujio Kasumi, Toshihiko Iwanaga, Fumio Konishi, Masaaki Terada, Hiro Wakasugi.   

Abstract

In the present study, we examined hemodynamics in vasculogenic mimicry (VM) and angiogenesis of inflammatory breast cancer (IBC) xenografts (WIBC-9), having previously reported on the unique histological features and molecular basis of these processes (K. Shirakawa et al., Cancer Res., 61: 445-451, 2001). Histologically, the WIBC-9 xenografts exhibited invasive ductal carcinoma with a hypervascular structure (angiogenesis) in the tumor margin and VM without endothelial cells, central necrosis, or fibrosis in the tumor center. Results of molecular analysis indicated that WIBC-9 had a vasculogenic phenotype, including expression of Flt-1 and Tie-2. Comparison of WIBC-9 with an established non-IBC xenograft (MC-5), using time-coursed dynamic micromagnetic resonance angiography analysis (with our newly developed intravascular macromolecular magnetic resonance imaging contrast agent), electromicroscopy, and immunohistochemistry, demonstrated blood flow and a VM-angiogenesis junction in the central area of the WIBC-9 tumor. It has previously been considered impossible to prove a connection between VM and angiogenesis using angiography, because there are no intravascular macromolecular magnetic resonance imaging contrast agents that do not exhibit significant leakage through the vascular wall. In the present study, laser-captured microdissection was performed in regions of WIBC-9 tumors that exhibited VM without endothelial cells, central necrosis, or fibrosis, revealing expression of human-Flt-1 and human-Tie2 and the absence of human-CD31, human-endothelin B receptor, and human-thrombin receptor. These facts led us to hypothesize that the VM of WIBC-9 involves hemodynamics that serve to feed WIBC-9 cells, and this in turn suggests a connection between VM and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11809710

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  73 in total

Review 1.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  Derived vascular endothelial cells induced by mucoepidermoid carcinoma cells: 3-dimensional collagen matrix model.

Authors:  Sen Yang; Li-juan Guo; Qing-hong Gao; Ming Xuan; Ke Tan; Qiang Zhang; Yu-ming Wen; Chang-mei Wang; Xiu-fa Tang; Xiao-yi Wang
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

3.  Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.

Authors:  Amy Y Lin; Zhuming Ai; Sang-Chul Lee; Peter Bajcsy; Jacob Pe'er; Lu Leach; Andrew J Maniotis; Robert Folberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

Review 4.  Interaction between gastric cancer stem cells and the tumor microenvironment.

Authors:  Takatsugu Ishimoto; Hiroshi Sawayama; Hidetaka Sugihara; Hideo Baba
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

5.  Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

Authors:  D Wang; C R Stockard; L Harkins; P Lott; C Salih; K Yuan; D Buchsbaum; A Hashim; M Zayzafoon; R W Hardy; O Hameed; W Grizzle; G P Siegal
Journal:  Biotech Histochem       Date:  2008-06       Impact factor: 1.718

6.  Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer.

Authors:  Michelle M Martínez-Montemayor; Raysa Rosario Acevedo; Elisa Otero-Franqui; Luis A Cubano; Suranganie F Dharmawardhane
Journal:  Nutr Cancer       Date:  2011-09-02       Impact factor: 2.900

7.  A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells.

Authors:  Ralph A Francescone; Michael Faibish; Rong Shao
Journal:  J Vis Exp       Date:  2011-09-07       Impact factor: 1.355

Review 8.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

Review 9.  Tumour vascularization: sprouting angiogenesis and beyond.

Authors:  Femke Hillen; Arjan W Griffioen
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

10.  Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells.

Authors:  Rihong Cong; Qingmin Sun; Li Yang; Haijuan Gu; Ying Zeng; Bin Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.